Tobacco Device Hits Snag as Experts Question Disease Dangers

  • Panel says Philip Morris failed to show reduced health risks
  • Stocks of tobacco giant and iQos partner Altria suffer a blow

Philip Morris Int'l CEO Bets on Smoke-Free Products

Lock
This article is for subscribers only.

Philip Morris International Inc. failed to convince health experts that its tobacco-heating product reduces the risk of smoking-related disease, a setback that raises questions about whether potential cigarette alternatives are really safer than smoking.

A Food and Drug Administration advisory panel concluded on Thursday in an 8-0 vote with one abstention that Philip Morris hadn’t shown that its iQos device, which heats tobacco to a lower temperature than lighting a cigarette, reduces the risk of tobacco-related ailments for smokers who make a complete switch.